local_hospital

Diagnostic Consulting Center 1 Velingrad EOOD

Address
Bulevard Siedinenie 49, 4600 Velingrad, Bulgaria

Nutritional and Metabolic Diseases

At Diagnostic Consulting Center 1 Velingrad EOOD in Velingrad, clinical research in Nutritional and Metabolic Diseases focuses on conditions linked to cardiovascular disease. The studies are centered on understanding how new approaches may help reduce major heart and blood vessel complications and improve long-term health outcomes.

  • Research into cardiovascular disease and related metabolic risk
  • Evaluation of a new therapy aimed at preventing major adverse cardiovascular events
  • Clinical work exploring better treatment options for people living with heart and blood vessel disease

This site contributes to research that may support more effective prevention strategies and better care for patients affected by metabolic conditions with cardiovascular impact.

Site Overview

assignment
20
connected trials
corporate_fare
12
sponsors
science
19
IMPs

Activity Indicator

Last 6 months

8
Trials started
+700% vs previous period.
1
Trials started 6–12 months ago
20
Total trials linked
Highly Active
trending_upGrowing+700%
1
1
3
1
2
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 10 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
12
Sponsors (total)
12
Active sponsors
9

Sponsor Network

Top 9 by active trials.

lock +8 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +3 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
20
Outperforms 85% of sites
public
Therapeutic diversity
10areas
Outperforms 93% of sites
groups
Sponsor diversity
12sponsors
Outperforms 84% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Diagnostic Consulting Center 1 Velingrad EOOD

lock Showing 1 of 20 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Dose Levels of ESK-001 in Adult Patients with Systemic Lupus ErythematosusAlumis Inc.Phase IINot RecruitingOct 2023

IMP list

lock Showing 1 of 19 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Azd50042Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.